{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:03:20Z","timestamp":1791921800870,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["ERS-LTRF 2011-131"],"award-info":[{"award-number":["ERS-LTRF 2011-131"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["FP7-PEOPLE-IEF 300371"],"award-info":[{"award-number":["FP7-PEOPLE-IEF 300371"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["TAMOP4.2.4.A\/ 2-11\/1-2012-0001"],"award-info":[{"award-number":["TAMOP4.2.4.A\/ 2-11\/1-2012-0001"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12890-016-0211-7","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T12:03:36Z","timestamp":1460635416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"16","author":[{"given":"Domokos","family":"Bartis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Borthwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit E.","family":"Pongr\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Langman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Thickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"211_CR1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/thoraxjnl-2014-206284","volume":"69","author":"DR Thickett","year":"2014","unstructured":"Thickett DR, Kendall C, Spencer LG, Screaton N, Wallace WA, Pinnock H, Bott J, Pigram L, Watson S, Millar AB. Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK:a round table discussion. Thorax. 2014;69:1136\u201340.","journal-title":"Thorax"},{"key":"211_CR2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/thx.2010.148031","volume":"66","author":"V Navaratnam","year":"2011","unstructured":"Navaratnam V, Fleming KM, West J, Smith CJP, Jenkins RG, Fogarty A, Hubbard RB. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax. 2011;66:462\u20137.","journal-title":"Thorax"},{"key":"211_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1183\/09059180.00011414","volume":"24","author":"U Costabel","year":"2015","unstructured":"Costabel U. The changing treatment landscape in idiopathic pulmonary fibrosis. Eur Respir Rev. 2015;24:65\u20138.","journal-title":"Eur Respir Rev"},{"key":"211_CR4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","volume":"171","author":"A Azuma","year":"2005","unstructured":"Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, Sato A, Kudoh S. Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Criti Care Med. 2005;171:1040\u20137.","journal-title":"Am J Respir Criti Care Med"},{"key":"211_CR5","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. N Engl J Med. 2014;370:2071\u201382.","journal-title":"N Engl J Med"},{"key":"211_CR6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/thoraxjnl-2011-201269","volume":"68","author":"G Raghu","year":"2013","unstructured":"Raghu G, Thickett DR. Pirfenidone for IPF: pro\/con debate;the \u2018con\u2019 viewpoint. Thorax. 2013;68:605\u20138.","journal-title":"Thorax"},{"key":"211_CR7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/thoraxjnl-2013-204608","volume":"69","author":"D Bartis","year":"2014","unstructured":"Bartis D, Mise N, Mahida RY, Eickelberg O, Thickett DR. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important? Thorax. 2014;69:760\u20135.","journal-title":"Thorax"},{"key":"211_CR8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/thx.2008.102814","volume":"64","author":"AG Richter","year":"2009","unstructured":"Richter AG, McKeown S, Rathinam S, Harper L, Rajesh P, McAuley DF, Heljasvaara R, Thickett DR. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax. 2009;64:156\u201361.","journal-title":"Thorax"},{"key":"211_CR9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1753465810379801","volume":"4","author":"WR Coward","year":"2010","unstructured":"Coward WR, Saini G, Jenkins G. The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2010;4:367\u201388.","journal-title":"Ther Adv Respir Dis"},{"key":"211_CR10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1513\/pats.201201-011AW","volume":"9","author":"SH Phan","year":"2012","unstructured":"Phan SH. Genesis of the Myofibroblast in Lung Injury and Fibrosis. Proc Am Thorac Soc. 2012;9:148\u201352.","journal-title":"Proc Am Thorac Soc"},{"key":"211_CR11","doi-asserted-by":"crossref","first-page":"E1475","DOI":"10.1073\/pnas.1117988108","volume":"108","author":"JR Rock","year":"2011","unstructured":"Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, Noble PW, Hogan BLM. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A. 2011;108:E1475\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"211_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00418-008-0388-9","volume":"129","author":"M Yamada","year":"2008","unstructured":"Yamada M, Kuwano K, Maeyama T, Hamada N, Yoshimi M, Nakanishi Y, Kasper M. Dual-immunohistochemistry provides little evidence for epithelial\u2013mesenchymal transition in pulmonary fibrosis. Histochem Cell Biol. 2008;129:453\u201362.","journal-title":"Histochem Cell Biol"},{"key":"211_CR13","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1073\/pnas.89.22.10832","volume":"89","author":"WJ Rettig","year":"1992","unstructured":"Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci U S A. 1992;89:10832\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"211_CR14","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.febslet.2005.03.071","volume":"579","author":"JR MacFadyen","year":"2005","unstructured":"MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, Panico M, Sutton-Smith M, Dell A, Van Der Geer P, Wienke D, Buckley CD, Isacke CM. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett. 2005;579:2569\u201375.","journal-title":"FEBS Lett"},{"key":"211_CR15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mvr.2008.07.008","volume":"76","author":"RG Bagley","year":"2008","unstructured":"Bagley RG, Honma N, Weber W, Boutin P, Rouleau C, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA. Endosialin\/TEM 1\/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvasc Res. 2008;76:180\u20138.","journal-title":"Microvasc Res"},{"key":"211_CR16","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1002\/art.34556","volume":"64","author":"AJ Naylor","year":"2012","unstructured":"Naylor AJ, Azzam E, Smith S, Croft A, Poyser C, Duffield JS, Huso DL, Gay S, Ospelt C, Cooper MS, Isacke C, Goodyear SR, Rogers MJ, Buckley CD. The mesenchymal stem cell marker CD248 (Endosialin) is a negative regulator of bone formation in mice. Arthritis Rheum. 2012;64:3334\u201343.","journal-title":"Arthritis Rheum"},{"key":"211_CR17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/eji.200939877","volume":"40","author":"S Lax","year":"2010","unstructured":"Lax S, Hardie DL, Wilson A, Douglas MR, Anderson G, Huso D, Isacke CM, Buckley CD. The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansion. Eur J Immunol. 2010;40:1884\u20139.","journal-title":"Eur J Immunol"},{"key":"211_CR18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4161\/cbt.9.11.11731","volume":"9","author":"B Tomkowicz","year":"2010","unstructured":"Tomkowicz B, Rybinski K, Nicolaides NC, Grasso L, Zhou Y. Endosialin\/TEM-1\/CD248 regulates pericyte proliferation through PDGF receptor signaling. Cancer Biol Ther. 2010;9:908\u201315.","journal-title":"Cancer Biol Ther"},{"key":"211_CR19","first-page":"73","volume":"39","author":"C Rouleau","year":"2011","unstructured":"Rouleau C, Smale R, Fu Y-S, Hui G, Wang F, Hutto E, Fogle R, Jones CM, Krumbholz R, Roth S, Curiel M, Ren Y, Bagley RG, Wallar G, Miller G, Schmid S, Horten B, Teicher BA. Endosialin is expressed in high grade and advanced sarcomas:evidence from clinical specimens and preclinical modelling. Int J Oncol. 2011;39:73\u201389.","journal-title":"Int J Oncol"},{"key":"211_CR20","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1002\/art.27701","volume":"62","author":"M Maia","year":"2010","unstructured":"Maia M, de Vriese A, Janssens T, Moons M, van Landuyt K, Tavernier J, Lories RJ, Conway EM. CD248 and its cytoplasmic domain:A therapeutic target for arthritis. Arthritis Rheum. 2010;62:3595\u2013606.","journal-title":"Arthritis Rheum"},{"key":"211_CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ki.2011.103","volume":"80","author":"SW Smith","year":"2011","unstructured":"Smith SW, Eardley KS, Croft AP, Nwosu J, Howie AJ, Cockwell P, Isacke CM, Buckley CD, Savage COS. CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int. 2011;80:199\u2013207.","journal-title":"Kidney Int"},{"key":"211_CR22","first-page":"291","volume":"23","author":"AC Ruifrok","year":"2001","unstructured":"Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001;23:291\u20139.","journal-title":"Anal Quant Cytol Histol"},{"key":"211_CR23","first-page":"137","volume":"56","author":"IR Witherden","year":"2001","unstructured":"Witherden IR, Tetley TD. Isolation and Culture of Human Alveolar Type II Pneumocytes. Methods Mol Med. 2001;56:137\u201346.","journal-title":"Methods Mol Med"},{"key":"211_CR24","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1016\/j.febslet.2007.06.063","volume":"581","author":"S Lax","year":"2007","unstructured":"Lax S, Hou TZ, Jenkinson E, Salmon M, MacFadyen JR, Isacke CM, Anderson G, Cunningham AF, Buckley CD. CD248\/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair. FEBS Lett. 2007;581:3550\u20136.","journal-title":"FEBS Lett"},{"key":"211_CR25","doi-asserted-by":"crossref","first-page":"e2142","DOI":"10.1371\/journal.pone.0002142","volume":"3","author":"M K\u00f6nigshoff","year":"2008","unstructured":"K\u00f6nigshoff M, Balsara N, Pfaff E-M, Kramer M, Chrobak I, Seeger W, Eickelberg O. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS One. 2008;3:e2142.","journal-title":"PLoS One"},{"key":"211_CR26","first-page":"58","volume":"5","author":"NJ Lomas","year":"2012","unstructured":"Lomas NJ, Watts KL, Akram KM, Forsyth NR, Spiteri MA. Idiopathic pulmonary fibrosis:immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers. Int J Clin Exp Pathol. 2012;5:58\u201371.","journal-title":"Int J Clin Exp Pathol"},{"key":"211_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2407-14-113","volume":"14","author":"S Suresh Babu","year":"2014","unstructured":"Suresh Babu S, Valdez Y, Xu A, O\u2019Byrne AM, Calvo F, Lei V, Conway EM. TGF\u03b2-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells. BMC Cancer. 2014;14:113.","journal-title":"BMC Cancer"},{"key":"211_CR28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2353\/ajpath.2008.070623","volume":"172","author":"S Christian","year":"2008","unstructured":"Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, Augustin HG. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol. 2008;172:486\u201394.","journal-title":"Am J Pathol"},{"key":"211_CR29","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1158\/1078-0432.CCR-08-0499","volume":"14","author":"C Rouleau","year":"2008","unstructured":"Rouleau C, Curiel M, Weber W, Smale R, Kurtzberg L, Mascarello J, Berger C, Wallar G, Bagley R, Honma N, Hasegawa K, Ishida I, Kataoka S, Thurberg BL, Mehraein K, Horten B, Miller G, Teicher BA. Endosialin protein expression and therapeutic target potential in human solid tumors:sarcoma versus carcinoma. Clin Cancer Res. 2008;14:7223\u201336.","journal-title":"Clin Cancer Res"},{"key":"211_CR30","doi-asserted-by":"crossref","first-page":"L442","DOI":"10.1152\/ajplung.00026.2010","volume":"299","author":"AL Degryse","year":"2010","unstructured":"Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010;299:L442\u201352.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"211_CR31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.200903-0322OC","volume":"180","author":"H Tanjore","year":"2009","unstructured":"Tanjore H, Xu XC, Polosukhin VV, Degryse AL, Li B, Han W, Sherrill TP, Plieth D, Neilson EG, Blackwell TS, Lawson WE. Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis. Am J Respir Crit Care Med. 2009;180:657\u201365.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-016-0211-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:59:28Z","timestamp":1498287568000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-016-0211-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1186\/s12890-016-0211-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,14]]},"article-number":"51"}}